SPRB insiders were on both sides of the trade this year. Buys came to roughly $4,585 (one buyer), sales to $4,921 (one seller).
Parkman Healthcare Partners LLC (10% Owner) made the biggest buy, worth around $4,585.
Big money check: 63 institutions held SPRB as of Q2 2026, and more funds bought than sold. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell | 232 | $19.33 | $4K | SEC |
| Oct 15, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Buy | 256 | $17.91 | $5K | SEC |
| Oct 15, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell | 25 | $17.46 | $436 | SEC |
| Oct 8, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell | 232 | $19.33 | $4K | SEC |
| Oct 8, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell | 25 | $17.46 | $436 | SEC |
| Oct 8, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Buy | 256 | $17.91 | $5K | SEC |
| Mar 25, 2024 | Novo Holdings A/S | 10% Owner | Sell | 465,021 | $0.75 | $349K | SEC |
| Mar 20, 2024 | Novo Holdings A/S | 10% Owner | Sell | 842,020 | $0.77 | $648K | SEC |
| Mar 20, 2024 | Novo Holdings A/S | 10% Owner | Sell | 359,979 | $0.73 | $263K | SEC |
| Mar 20, 2024 | Novo Holdings A/S | 10% Owner | Sell | 593,000 | $0.76 | $451K | SEC |
| Mar 18, 2024 | Novo Holdings A/S | 10% Owner | Sell | 1,912,316 | $0.89 | $1.7M | SEC |
| May 16, 2023 | O'Donnell Niall | Director | Buy | 630,400 | $3.17 | $2.0M | SEC |
| Feb 21, 2023 | Novo Holdings A/S | 10% Owner | Buy | 2,208,000 | $3.17 | $7.0M | SEC |
In the last 12 months Spruce Biosciences, Inc. insiders made open-market purchases worth about $4,585 and sales worth about $4,921. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SPRB was filed on 2025-10-15.
63 investment managers reported holding SPRB in SEC Form 13F filings for Q2 2026.
No congressional trades in SPRB were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).